ArticlePloS one2013

Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy.

Adam Szulkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.